Selected research
Industry Research
Biopharmaceutical Process Development Services Industry Research Report 2026
Market perspective
The global Biopharmaceutical Process Development Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Biopharmaceutical Process Development Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Biopharmaceutical Process Development Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Biopharmaceutical Process Development Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Biopharmaceutical Process Development Services include Merck Millipore, Cytiva, Coriolis Pharma, Lonza, Premas Biotech, Kemwell Biopharma, Avantor, Pace Life Sciences and KBI Biopharma, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Biopharmaceutical Process Development Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biopharmaceutical Process Development Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biopharmaceutical Process Development Services Market by Company
Merck Millipore
Cytiva
Coriolis Pharma
Lonza
Premas Biotech
Kemwell Biopharma
Avantor
Pace Life Sciences
KBI Biopharma
Rommelag
FyoniBio
Rentschler Biopharma SE
BioPharma Services
GenIbet
Biopharmaceutical Process Development Services Segment by Type
Cell Culture
Upstream Process Development
Downstream Process Development
Biopharmaceutical Process Development Services Segment by Application
Small and Medium Enterprises
Large Enterprises
Biopharmaceutical Process Development Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceutical Process Development Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceutical Process Development Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceutical Process Development Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biopharmaceutical Process Development Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cell Culture
- Upstream Process Development
- Downstream Process Development
Applications
- Small and Medium Enterprises
- Large Enterprises
Companies covered
- Merck Millipore
- Cytiva
- Coriolis Pharma
- Lonza
- Premas Biotech
- Kemwell Biopharma
- Avantor
- Pace Life Sciences
- KBI Biopharma
- Rommelag
- FyoniBio
- Rentschler Biopharma SE
- BioPharma Services
- GenIbet
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biopharmaceutical Process Development Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cell Culture
- 2.2.3 Upstream Process Development
- 2.2.4 Downstream Process Development
- 2.3 Biopharmaceutical Process Development Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Small and Medium Enterprises
- 2.3.3 Large Enterprises
- 2.4 Assumptions and Limitations
3 Biopharmaceutical Process Development Services Breakdown Data by Type
- 3.1 Global Biopharmaceutical Process Development Services Historic Market Size by Type (2021-2026)
- 3.2 Global Biopharmaceutical Process Development Services Forecasted Market Size by Type (2027-2032)
4 Biopharmaceutical Process Development Services Breakdown Data by Application
- 4.1 Global Biopharmaceutical Process Development Services Historic Market Size by Application (2021-2026)
- 4.2 Global Biopharmaceutical Process Development Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Biopharmaceutical Process Development Services Market Perspective (2021-2032)
- 5.2 Global Biopharmaceutical Process Development Services Growth Trends by Region
- 5.2.1 Global Biopharmaceutical Process Development Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Biopharmaceutical Process Development Services Historic Market Size by Region (2021-2026)
- 5.2.3 Biopharmaceutical Process Development Services Forecasted Market Size by Region (2027-2032)
- 5.3 Biopharmaceutical Process Development Services Market Dynamics
- 5.3.1 Biopharmaceutical Process Development Services Industry Trends
- 5.3.2 Biopharmaceutical Process Development Services Market Drivers
- 5.3.3 Biopharmaceutical Process Development Services Market Challenges
- 5.3.4 Biopharmaceutical Process Development Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Biopharmaceutical Process Development Services Players by Revenue
- 6.1.1 Global Top Biopharmaceutical Process Development Services Players by Revenue (2021-2026)
- 6.1.2 Global Biopharmaceutical Process Development Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Biopharmaceutical Process Development Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biopharmaceutical Process Development Services Head Office and Area Served
- 6.4 Global Biopharmaceutical Process Development Services Players, Product Type & Application
- 6.5 Global Biopharmaceutical Process Development Services Manufacturers Established Date
- 6.6 Global Biopharmaceutical Process Development Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Biopharmaceutical Process Development Services Market Size (2021-2032)
- 7.2 North America Biopharmaceutical Process Development Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Biopharmaceutical Process Development Services Market Size by Country (2021-2026)
- 7.4 North America Biopharmaceutical Process Development Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Biopharmaceutical Process Development Services Market Size (2021-2032)
- 8.2 Europe Biopharmaceutical Process Development Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Biopharmaceutical Process Development Services Market Size by Country (2021-2026)
- 8.4 Europe Biopharmaceutical Process Development Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Biopharmaceutical Process Development Services Market Size (2021-2032)
- 9.2 Asia-Pacific Biopharmaceutical Process Development Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Biopharmaceutical Process Development Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Biopharmaceutical Process Development Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Biopharmaceutical Process Development Services Market Size (2021-2032)
- 10.2 South America Biopharmaceutical Process Development Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Biopharmaceutical Process Development Services Market Size by Country (2021-2026)
- 10.4 South America Biopharmaceutical Process Development Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Biopharmaceutical Process Development Services Market Size (2021-2032)
- 11.2 Middle East & Africa Biopharmaceutical Process Development Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Biopharmaceutical Process Development Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Biopharmaceutical Process Development Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Merck Millipore
- 12.1.1 Merck Millipore Company Information
- 12.1.2 Merck Millipore Business Overview
- 12.1.3 Merck Millipore Revenue in Biopharmaceutical Process Development Services Business (2021-2026)
- 12.1.4 Merck Millipore Biopharmaceutical Process Development Services Product Portfolio
- 12.1.5 Merck Millipore Recent Developments
- 12.2 Cytiva
- 12.2.1 Cytiva Company Information
- 12.2.2 Cytiva Business Overview
- 12.2.3 Cytiva Revenue in Biopharmaceutical Process Development Services Business (2021-2026)
- 12.2.4 Cytiva Biopharmaceutical Process Development Services Product Portfolio
- 12.2.5 Cytiva Recent Developments
- 12.3 Coriolis Pharma
- 12.3.1 Coriolis Pharma Company Information
- 12.3.2 Coriolis Pharma Business Overview
- 12.3.3 Coriolis Pharma Revenue in Biopharmaceutical Process Development Services Business (2021-2026)
- 12.3.4 Coriolis Pharma Biopharmaceutical Process Development Services Product Portfolio
- 12.3.5 Coriolis Pharma Recent Developments
- 12.4 Lonza
- 12.4.1 Lonza Company Information
- 12.4.2 Lonza Business Overview
- 12.4.3 Lonza Revenue in Biopharmaceutical Process Development Services Business (2021-2026)
- 12.4.4 Lonza Biopharmaceutical Process Development Services Product Portfolio
- 12.4.5 Lonza Recent Developments
- 12.5 Premas Biotech
- 12.5.1 Premas Biotech Company Information
- 12.5.2 Premas Biotech Business Overview
- 12.5.3 Premas Biotech Revenue in Biopharmaceutical Process Development Services Business (2021-2026)
- 12.5.4 Premas Biotech Biopharmaceutical Process Development Services Product Portfolio
- 12.5.5 Premas Biotech Recent Developments
- 12.6 Kemwell Biopharma
- 12.6.1 Kemwell Biopharma Company Information
- 12.6.2 Kemwell Biopharma Business Overview
- 12.6.3 Kemwell Biopharma Revenue in Biopharmaceutical Process Development Services Business (2021-2026)
- 12.6.4 Kemwell Biopharma Biopharmaceutical Process Development Services Product Portfolio
- 12.6.5 Kemwell Biopharma Recent Developments
- 12.7 Avantor
- 12.7.1 Avantor Company Information
- 12.7.2 Avantor Business Overview
- 12.7.3 Avantor Revenue in Biopharmaceutical Process Development Services Business (2021-2026)
- 12.7.4 Avantor Biopharmaceutical Process Development Services Product Portfolio
- 12.7.5 Avantor Recent Developments
- 12.8 Pace Life Sciences
- 12.8.1 Pace Life Sciences Company Information
- 12.8.2 Pace Life Sciences Business Overview
- 12.8.3 Pace Life Sciences Revenue in Biopharmaceutical Process Development Services Business (2021-2026)
- 12.8.4 Pace Life Sciences Biopharmaceutical Process Development Services Product Portfolio
- 12.8.5 Pace Life Sciences Recent Developments
- 12.9 KBI Biopharma
- 12.9.1 KBI Biopharma Company Information
- 12.9.2 KBI Biopharma Business Overview
- 12.9.3 KBI Biopharma Revenue in Biopharmaceutical Process Development Services Business (2021-2026)
- 12.9.4 KBI Biopharma Biopharmaceutical Process Development Services Product Portfolio
- 12.9.5 KBI Biopharma Recent Developments
- 12.10 Rommelag
- 12.10.1 Rommelag Company Information
- 12.10.2 Rommelag Business Overview
- 12.10.3 Rommelag Revenue in Biopharmaceutical Process Development Services Business (2021-2026)
- 12.10.4 Rommelag Biopharmaceutical Process Development Services Product Portfolio
- 12.10.5 Rommelag Recent Developments
- 12.11 FyoniBio
- 12.11.1 FyoniBio Company Information
- 12.11.2 FyoniBio Business Overview
- 12.11.3 FyoniBio Revenue in Biopharmaceutical Process Development Services Business (2021-2026)
- 12.11.4 FyoniBio Biopharmaceutical Process Development Services Product Portfolio
- 12.11.5 FyoniBio Recent Developments
- 12.12 Rentschler Biopharma SE
- 12.12.1 Rentschler Biopharma SE Company Information
- 12.12.2 Rentschler Biopharma SE Business Overview
- 12.12.3 Rentschler Biopharma SE Revenue in Biopharmaceutical Process Development Services Business (2021-2026)
- 12.12.4 Rentschler Biopharma SE Biopharmaceutical Process Development Services Product Portfolio
- 12.12.5 Rentschler Biopharma SE Recent Developments
- 12.13 BioPharma Services
- 12.13.1 BioPharma Services Company Information
- 12.13.2 BioPharma Services Business Overview
- 12.13.3 BioPharma Services Revenue in Biopharmaceutical Process Development Services Business (2021-2026)
- 12.13.4 BioPharma Services Biopharmaceutical Process Development Services Product Portfolio
- 12.13.5 BioPharma Services Recent Developments
- 12.14 GenIbet
- 12.14.1 GenIbet Company Information
- 12.14.2 GenIbet Business Overview
- 12.14.3 GenIbet Revenue in Biopharmaceutical Process Development Services Business (2021-2026)
- 12.14.4 GenIbet Biopharmaceutical Process Development Services Product Portfolio
- 12.14.5 GenIbet Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst